Prof. Dr. Flavia Franconi

Prof. Dr. Flavia Franconi

She is the spiritual founder of the Matera group since she organized the meeting “Gender and life style: from puberty to elderly frailty” in Matera (Italy) 14-16 April 2016 where the group was founded and gave the first and decisive input on its goals. In 2003, she organized the work group of Italian Pharmacological Society “Gender Pharmacology” with the goal to develop gender pharmacology in Italy. Since 2014 the “Gender Pharmacology Group” organized numerous meetings to increase gender culture. In 2009, she started to organize international meetings on gender medicine. The first was “Genes, drugs and gender “Sassari (Italy), October 1-2 and the latest was “Gender and life style: from puberty to elderly frailty” Matera (Italy) 14-16 April 2016. In 2005, she found and coordinated (2005-2013) the PhD in Gender Pharmacology of Sassari University. In 2009, she founded and became Chairman (2009-2014) of the Italian Group Health and Gender building a website for the dissemination of the gender culture. She collaborated with United Nation (Sex and Gender Analysis in Medical and Pharmacological Research) and with UNICRI (Approach to Addiction United Nations Interregional Crime and Justice Research Institute presented: 19 March 2014, Wien). She published more the 55 papers in international journals relatively to sex and gender aspects. Actually, is mainly focuses in studying how sex or gender should be included in preclinical studies and clinical trials.


Prof. Dr. Ineke Klinge

Ineke Klinge chairs the Horizon 2020 Advisory Group for Gender at the European Commission. In 2015 she was visiting professor at the Institute of Gender in Medicine (GiM) at Charité, Berlin. She has a background in biomedical sciences and gender research. As associate professor of Gender Medicine at Maastricht University (1998-2014) her work focused on innovation of methodologies for biomedical and health research. Since 2000 she has coordinated many EU projects of which the most recent one was the Gendered Innovations project together with Londa Schiebinger from Stanford University. This project developed methods of sex and gender analysis for basic and applied research and was presented in a special session in the European Parliament on July 9, 2013. With Claudia Wiesemann she published the book Sex and Gender in Biomedicine. Theories, Methodologies , Results (University press Göttingen, 2010). She is currently involved in EU projects as f.e. EUGenMed, GenCad, TRIGGER, LIBRA, Gedii and serves on the advisory board of the Institute for Gender and Health (Canada, until 2016)) and the European Institute for Women’s’ Health (EIWH). She is also member of the Dutch Alliance for Gender & Health that developed a research programme focusing on integration of sex and gender in health research and -care. The research program received a 4-year funding from the Dutch Ministry of Health in 2016.

Prof. Andrea Lenzi

Prof. Andrea Lenzi

Andrea Lenzi (Bologna, 1953) lives in Rome (Italy), where he is Full Professor of Endocrinology at Sapienza University of Rome and responsible for the Endocrinology, metabolism, obesity and Andrology branch at the Policlinico Umberto I University Hospital. His past roles at the same University include President of the Degree Course in Medicine and Director of the Department of Medical Pathophysiology (now an autonomous section of the Department of Experimental Medicine), while he is currently the Director of the PhD course in Endocrinological Sciences, of the Residency in Endocrinology and Metabolic Diseases. Professor Lenzi is acclaimed nationally and internationally as an expert in the pathophysiology of reproduction. He was Secretetary General of the international society of Immunology of Reproduction, a former Secretary General of the European Academy of Andrology and President of the Italian Society of Andrology and Sexual Medicine (SIAMS), and is currently President of the Italian Society of Endocrinology, President of the Permanent Conference of the Presidents of Degree Courses in Medicine and, finally, past President of the Italian National University Council, the highest level university body in Italy. He is also President of the Italian Committee for Biosafety, Biotechnology and Life Sciences operating under the Presidency of the Council of Ministers, President of the Ministry of Health’s Technical Scientific Committee and President of the Ministry of Education, University and Research’s National Committee of Guarantors for Research. He is currently Editor-in-Chief of the Major Reference Work in Endocrinology (Springer series) and Director of the monthly journal L’Endocrinologo. As Researcher in Endocrinology he has produced more than 750 publications, comprising full papers, books, monographs and chapters, including more than 400 original articles published in international journals (Impact factor >>2000; Hirsch Index 56).

William J. Martin, PhD

William J. Martin, PhD is currently Chief Scientific Officer and Head of Research and Development at BlackThorn Therapeutics, a biopharmaceutical company focused on creating new medicines for neurobehavioral disorders. A systems neuroscientist by training, Bill began his industrial career at Merck where he had research, development and strategic responsibilities in Neuroscience. Bill served as a member on the committee that oversaw the strategic direction of the Merck’s Neuroscience franchise as well as a co-chair for Early Development and Product Development teams for CNS drug candidates. Bill continued his career at Theravance Biopharma where, in addition to discovery and clinical development responsibilities, he led the company’s research portfolio planning initiative, was a member of the licensing and strategic partnership team and served as a Project Team Leader for an advanced clinical stage molecule for CNS disorders. His scientific career has focused on understanding central nervous system adaptations that contribute to the development pathophysiological conditions. Over the course of his industrial career, Bill has been responsible for advancing more than 10 novel chemical entities into preclinical development, with at least half of these reaching Phase 2. Bill remains an active member of the scientific community at-large. A co-author on more than 70 primary research and review articles, he is a former Councilor of the Society for Neuroscience (SfN), a current Chair of the Government and Public Affairs Committee of SfN and a member of the Advisory Council of the Brown Institute for Brain Science. He remains active in science policy, diversity and professional development. Bill graduated from Swarthmore College, earned his PhD from Brown University and carried out his postdoctoral research at the Keck Center for Integrative Neuroscience at the University of California at San Francisco.

Prof. Dr. Virginia Miller

Dr. Miller, a native of Pittsburgh, PA, is Professor of Surgery and Physiology and Director of the Women’s Health Research Center at Mayo Clinic, Rochester, MN. She received a BS in education from Slippery Rock University, Slippery Rock, PA and a PhD in Physiology from the University of Missouri, Columbia, MO. She broadened her education through a MBA from the University of Minnesota. Her research for the last 25 years has focused on how sex steroids affect vascular function. In addition to her basic science work, she was principal investigator for the Mayo site for the Kronos Early Estrogen Prevention Study (KEEPS), a double blind, placebo controlled clinical trial. She currently serves as principal investigator for Mayo Clinic’s Specialized Center of Research on Sex Differences and Principal Investigator of Mayo Clinic’s Building Interdisciplinary Careers in Women’s Health (BIRCWH) scholars program. She has authored over 250 original publications and reviews. She was the 2014 recipient of the Bernadine Healy Award for Visionary Leadership in Women’s Health from the Women’s Health Congress and a 2015 recipient of Women’s Day Magazine Red Dress Award for her work in research and advocacy for women’s health. She has worked with international groups in the promotion for the inclusion of sex and gender variables in basic and medical curricula and research including the web-based program Genderedinnovations.com, International Society of Gender Medicine and Sex and Gender Women’s Health Collaborative. In addition to service on various grant review panels and editorial boards for scientific journals, she served as a member of the governing council for the American Physiological Society (APS) and as President of the Organization for the Study of Sex Differences (OSSD).

Prof. Dr. Vera Regitz-Zagrosek

Prof. Dr. med. Dr. h.c. Vera Regitz-Zagrosek, FESC, is the founder of the Institute for Gender in Medicine (GiM) at Charite, Berlin and the founding President of the International and German Society for Gender in Medicine (IGM, DGesGM). The aim of the GiM is the systematic analysis of sex and gender differences in medicine and its introduction into medical education. Her research interests include gender differences in cardiovascular disease, estrogen receptors and molecular and genetic mechanisms in heart failure. She coordinates a number of EU projects in gender medicine and basic research (EUGIM, EUGENMED, GENCAD, RADOX). She also coordinates projects of German Federal Ministry of Education and Research (Gender and age, 2017-2021) and is the speaker of the Berlin site of the German Cardiovascular Research Center (DZHK). She is the founder and speaker of the only DFG funded coordinated basic research projects on sex differences “Sex-specific mecha¬nisms in myocardial hypertrophy”. She is task force leader of the ESC to develop Guidelines for the Management of Cardiovascular Diseases during Pregnancy. She is reviewer for the German Research Foundation (DFG), the European Union, international funding agencies and numerous journals. She published more than 150 scientific publications, and edited major textbooks in gender medicine.

Dr. Paula Rochon

Dr. Paula Rochon

Dr. Paula Rochon is a geriatrician and vice-president of research at Women’s College Hospital. She is the lead of Women’s Xchange, a women’s health research knowledge translation and exchange centre: www.womensxchange.ca One of the goals of Women’s Xchange is to enhance the integration of sex and gender in health research. Dr. Rochon is also a senior scientist at Women’s College Research Institute, a University of Toronto professor (department of medicine and the Institute of Health Policy Management and Evaluation) and a senior scientist at the Institute for Clinical Evaluative Sciences. In 2015, Dr. Rochon was named the inaugural RTO/ERO Chair in Geriatric Medicine at the University of Toronto. She received her medical degree from McMaster University and her Master of Public Health degree from the Harvard School of Public Health. Dr. Rochon studies vulnerable older adults with a particular focus on women. Her research explores how medical therapies impact the health of older adults with multiple conditions, focusing on sex and gender differences. She studies antipsychotic use in older people and strategies to optimize prescribing and reduce adverse drug events. She also advocates for clinical research studies to include older adults and report on different outcomes between men and women.

Hester den Ruijter, PhD

Hester den Ruijter (PhD) I am a translational scientist at the Laboratory of Experimental Cardiology in the University Medical Center Utrecht in the Netherlands. My research focusses on sex differences in cardiovascular diseases. I have been trained in fundamental research as well as in clinical epidemiology. Currently, I coordinate the Dutch Heart Foundation funded consortium Queen of Hearts, a consortium that works on biomarker discovery-a clinical test- to improve the diagnosis of cardiovascular disease in women. Next to my scientific research, I am a member of the Young Academy in the Netherlands where I contribute to the viewpoints and discussion on scientific policy in the Netherlands.

Prof. Karen Sliwa

Prof. Karen Sliwa, MD, PhD, FESC, FACC, DTM & H- is the Director of the Hatter Institute for Cardiovascular Research in Africa (www.hatter.uct.ac.za), University of Cape Town, South Africa. Born in Germany, studying Medicine, undergoing training as a physician and cardiologist in a number of countries, she lives in South Africa since 1992. Clinically her interests are in heart failure, rheumatic heart disease and all aspects of cardiovascular disease in pregnancy and postpartum. Her research spans from basic science to clinical studies to population studies. She has designed a number of innovative research programs and leveraged funding for several major research projects, not only in South Africa and the rest of Africa, but also internationally. She has published more than 200 articles and her work is highly cited. In recognition of her work Prof Sliwa has received several prestigious awards. Karen Sliwa serves on a number of editorial boards and is also an editorial consultant to ‘The Lancet’. Furthermore, she is the past president of the South African Heart Association, serves on the board of the South African Heart Failure Society (Hefssa; www.hefssa.org), which was established under her leadership 2005. She also president-elect World Heart Federation ( 2017-2019), a member of the European Cardiac Society International Affairs committee and is board member of the Pan African Society of Cardiology. Since March 2017 she is deputy dean research, Faculty of Health Sciences, University of Cape Town.

Dr. Cara Tannenbaum

Dr. Cara Tannenbaum is the Scientific Director of the Institute of Gender and Health at the Canadian Institutes of Health Research. She obtained her medical, specialist and research degrees at McGill University. Dr. Tannenbaum is a Professor in the Faculties of Medicine and Pharmacy at the Université de Montréal, where she holds the Chair in Pharmacology, Health and Aging. Her research focuses on sex and gender differences, and patient education in the area of drug safety. As Scientific Director of the Canadian Institute of Gender and Health, Dr. Tannenbaum works with national and international research communities, funding organisations, industry and stakeholders to identify research priorities, strengthen research capacity, build partnerships and translate research evidence into policy and practice to improve the health of boys, girls, men, women and gender-diverse persons. She was awarded the May Cohen Gender Equity Award presented by the Association of Faculties of Medicine of Canada to recognize outstanding achievement in improving the gender equity environment in academic medicine in Canada.

Jill Becker
Danielle Day
Karolina Kublickiene
Kathryn Sandberg
Hiroaki Shimokawa